HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuhiko Yamamoto Selected Research

Ligands

10/2003Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.
1/2003Variations in the human Th2-specific chemokine TARC gene.
7/2002Spatial raft coalescence represents an initial step in Fc gamma R signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuhiko Yamamoto Research Topics

Disease

95Rheumatoid Arthritis
11/2023 - 09/2002
41Autoimmune Diseases (Autoimmune Disease)
02/2024 - 02/2002
28Inflammation (Inflammations)
01/2019 - 03/2002
26Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2024 - 09/2004
22Neoplasms (Cancer)
07/2023 - 08/2002
17Arthritis (Polyarthritis)
01/2021 - 11/2003
11Squamous Cell Carcinoma of Head and Neck
09/2022 - 03/2007
11Experimental Arthritis
04/2016 - 06/2005
11Asthma (Bronchial Asthma)
02/2016 - 01/2003
9Infections
07/2023 - 09/2007
7Eosinophilia
09/2013 - 10/2003
5Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021 - 01/2013
5Disease Progression
06/2018 - 10/2008
4Lymphoma (Lymphomas)
01/2024 - 01/2004
4Melanoma (Melanoma, Malignant)
02/2023 - 04/2006
4Necrosis
01/2021 - 06/2004
4Vasculitis (Vasculitides)
01/2021 - 05/2009
4Lupus Nephritis
01/2020 - 09/2004
4Pneumonia (Pneumonitis)
01/2018 - 06/2004
4Hypersensitivity (Allergy)
02/2016 - 08/2003
4Mandibular Fractures
01/2013 - 07/2010
4Anaphylaxis (Anaphylactic Shock)
06/2011 - 03/2002
3Neoplasm Metastasis (Metastasis)
09/2022 - 09/2008
3Pain (Aches)
01/2021 - 08/2011
3Osteoporosis
07/2020 - 09/2013
3Drug-Related Side Effects and Adverse Reactions
03/2019 - 01/2014
3Genetic Predisposition to Disease (Genetic Predisposition)
01/2018 - 05/2009
3Glomerulonephritis
12/2017 - 05/2007
3Wounds and Injuries (Trauma)
10/2016 - 01/2011
3Fibrosis (Cirrhosis)
04/2016 - 10/2005
3Thrombotic Thrombocytopenic Purpura
11/2015 - 01/2011
3Fever (Fevers)
01/2015 - 05/2013
3Facial Injuries (Facial Injury)
01/2013 - 06/2011
3Nephritis
11/2012 - 09/2007
3Fanconi Anemia (Fanconi's Anemia)
03/2008 - 08/2003
3Carcinogenesis
03/2008 - 09/2003
3Allergic Rhinitis
01/2008 - 09/2006

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2002
27CytokinesIBA
01/2021 - 03/2002
24AutoantibodiesIBA
01/2022 - 08/2003
17Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 01/2009
17AntigensIBA
10/2016 - 07/2002
12tocilizumab (atlizumab)FDA Link
05/2020 - 09/2007
12HLA-DRB1 Chains (HLA DRB1)IBA
01/2019 - 01/2004
12AutoantigensIBA
03/2016 - 02/2002
10AntibodiesIBA
01/2022 - 01/2003
9Certolizumab PegolFDA Link
03/2020 - 07/2014
8DNA (Deoxyribonucleic Acid)IBA
01/2024 - 08/2003
7EnzymesIBA
11/2022 - 08/2003
7Rituximab (Mabthera)FDA Link
02/2021 - 01/2007
7Peptides (Polypeptides)IBA
05/2015 - 08/2003
6Adrenal Cortex Hormones (Corticosteroids)IBA
01/2023 - 09/2002
6InterleukinsIBA
01/2021 - 08/2002
6Protein-Arginine DeiminasesIBA
01/2020 - 08/2003
6Immunoglobulin E (IgE)IBA
10/2018 - 09/2005
6Antirheumatic Agents (DMARD)IBA
09/2018 - 09/2007
6Interleukin-10 (Interleukin 10)IBA
01/2018 - 06/2005
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2017 - 06/2004
5Prednisolone (Predate)FDA LinkGeneric
01/2021 - 10/2003
5golimumabFDA Link
09/2018 - 06/2012
5EpitopesIBA
01/2018 - 01/2004
5Tacrolimus (Prograf)FDA LinkGeneric
12/2017 - 10/2011
5Anti-Citrullinated Protein AntibodiesIBA
06/2016 - 12/2009
5Interleukin-6 (Interleukin 6)IBA
08/2015 - 08/2002
4T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2024 - 11/2007
4Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2021 - 05/2009
4Antigen-Antibody Complex (Immune Complex)IBA
01/2020 - 05/2007
4Transcription Factors (Transcription Factor)IBA
01/2020 - 06/2010
4Immunoglobulin G (IgG)IBA
01/2019 - 04/2006
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2017 - 01/2004
4acetyl 4-aminosalicylic acidIBA
04/2016 - 01/2011
4Immunoglobulins (Immunoglobulin)IBA
03/2016 - 05/2007
4Protein-Arginine Deiminase Type 4IBA
01/2016 - 11/2003
4AllergensIBA
01/2013 - 09/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2010 - 03/2007
4micaIBA
08/2009 - 07/2007
4OvalbuminIBA
01/2009 - 01/2004
4Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2009 - 08/2002
4Nucleosomes (Nucleosome)IBA
10/2008 - 08/2004
4Messenger RNA (mRNA)IBA
02/2006 - 08/2002
3InterferonsIBA
01/2023 - 04/2003
3Fc Receptors (Fc Receptor)IBA
01/2023 - 05/2005
3HLA Antigens (Human Leukocyte Antigens)IBA
12/2022 - 01/2019
3GlucocorticoidsIBA
07/2020 - 07/2019
3anti-dsDNA autoantibodyIBA
01/2020 - 11/2012
3iguratimodIBA
03/2019 - 05/2013
3Interleukin-33IBA
01/2016 - 11/2008
3thiamine triphosphorate (TTP)IBA
11/2015 - 01/2011
3ElementsIBA
04/2014 - 09/2004
3Interleukin-4 (Interleukin 4)IBA
01/2012 - 01/2004
3cyclic citrullinated peptideIBA
01/2011 - 12/2009
3Vascular Endothelial Growth Factor CIBA
08/2010 - 03/2007
3CitrullineIBA
09/2008 - 11/2003
3Mitomycin (Mitomycin-C)FDA LinkGeneric
03/2008 - 08/2003

Therapy/Procedure

36Therapeutics
11/2023 - 05/2004
5Jaw Fixation Techniques
01/2013 - 07/2010
5Immunotherapy
01/2008 - 01/2004
4General Anesthesia
01/2021 - 08/2010
3Tooth Extraction (Tooth Extractions)
01/2019 - 01/2016
3Oral Administration
03/2016 - 02/2006